Citigroup »

Maze Therapeatics shares owned by Citigroup

Quarter-by-quarter ownership of Maze Therapeatics (MAZE) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Maze Therapeatics

Tip: Access up to 7 years of quarterly data

All positions including Maze Therapeatics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maze Therapeatics by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $256k 8.6k 29.85
2025-03-31 $68k 6.2k 11.01

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Maze Therapeatics

Frazier Life Sciences Management
Trv Gp Iv
Arch Venture Corp
Deep Track Capital
Henderson Group
Paradigm Biocapital Advisors
BlackRock
AH Capital Management
Vanguard Group
VR Adviser
Vanguard Capital Management
Alphabet
Logos Global Management
General Catalyst Group Management
TRV GP V

View all funds holding Maze Therapeatics